Yüklüyor......
Ultralow-Dose Adjunctive Methadone with Slow Titration, Considering Long Half-Life, for Outpatients with Cancer-Related Pain
Background: The unique properties of methadone make it attractive for use in cancer pain. The use of very low initial doses of adjunctive methadone is a promising strategy given its simplicity and potentially reduced risk profile. Objective: To understand if an ultralow-dose (ULD) methadone protocol...
Kaydedildi:
| Yayımlandı: | Palliat Med Rep |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Mary Ann Liebert, Inc., publishers
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8241322/ https://ncbi.nlm.nih.gov/pubmed/34223466 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/pmr.2020.0034 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|